Dejan Hušman | Chief Executive Officer

Dejan Hušman, Chief Executive Officer, denovoMATRIX

Dejan Hušman is the CEO of denovoMATRIX, a biotech spin-out from the TU Dresden in Germany. Dejan has a background in Molecular Bioengineering and Biomaterials, having completed his PhD in Dresden, in the group of Prof. Carsten Werner. Following his studies, began his work on denovoMATRIX - starting first as a government funded project in 2016, and following on with the   raising the first financing round in 2018 with the High Tech Gründer Fonds/Technologie Gründer Fonds Sachsen.


Conference Day 2 - Wednesday 1st April 2020 @ 15:30

denovoMATRIX enabling human biology in vitro

  • Stem cells are an essential resource required for cell-based therapies, and currently methods are lacking for manufacturing stem cells at scale
  • denovoMATRIX has developed a platform technology of biomimetic coatings which enable stem cell expansion - most recently the rapid growth of MSC in serum-free conditions
  • Our next aim is to bring to market our coating for iPSC expansion, and thereby enable the next generation of cell-based therapies based on iPS
last published: 04/Jun/20 08:25 GMT

back to speakers